Golar LNG Limited – Q3 2024 results presentation
Golar LNG's 3rd Quarter 2024 results will be released before the NASDAQ opens on Tuesday, November 12, 2024. In connection with this a webcast ...
Golar LNG to Announce Q3 2024 Financial Results
Golar LNG (GLNG) has released an update. Golar LNG is set to unveil its third-quarter 2024 financial results on November 12, with a live ...
RMA Global’s Strategic Acquisition and Equity Initiative
RMA Global Ltd. (AU:RMY) has released an update. RMA Global Ltd. is set to acquire Steps Marketing, Inc., known as Curated Social, while ...
Square still looking for Wells Fargo replacement, The Information says
For more than two decades, Wells Fargo (WFC) was a juggernaut in a behind-the-scenes business that supported some of the biggest payments ...
CAVA Group, Inc. (CAVA) Gets a Hold from Morgan Stanley
In a report released today, Brian Harbour from Morgan Stanley maintained a Hold rating on CAVA Group, Inc. (CAVA – Research Report), with ...
Personal AI to Bring Enterprise-Grade AI to the NPU on PCs powered by Snapdragon X Series Processors
Showcased during Snapdragon Summit, Personal AI's SLMs were demonstrated on HP EliteBook Ultra Next-Gen AI PCs powered by ...
Editas Medicine and Genevant Sciences to Collaborate to Develop Novel mRNA-LNP Gene Editing Therapeutics
CAMBRIDGE, Mass. and VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: ...
Ripple Co-Founder Larsen Flooding Kamala Harris' Election Effort With XRP
Ripple co-founder Chris Larsen said he amplified his support for Vice President Kamala Harris, adding $10 million worth of XRP to her election ...
Stock market today: US stocks pull back from record levels as traders ready for big week of earnings
Company executives are striking an optimistic tone on recent earnings calls, according to Bank of America strategist Savita ...
BioVie Inc. Announces Pricing of Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
BioVie Inc. (NASDAQ: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...
Wall Street keeps raising price targets for sky-high Nvidia stock. Here's why analysts are still so bullish.
Strategists said they changed their price target after a meeting with Huang. The Nvidia CEO spoke of the company's advantage ...
Elections have little impact on stock prices. Here's what investors should focus on instead.
Recent elections have shown unexpected sector impacts, highlighting the importance of sustainable profit growth, BofA said.